Archive: 2006 Early-Stage Life Sciences Technology Conference II

May 1, 2006, 12:45-7:00 pm
The Conference Center at Harvard Medical School
77 Avenue Louis Pasteur, Boston , MA

Conference Description

Presenters and Exhibitors include BioBehavioral Diagnostics, Contego Pharmaceuticals, P.A. Technologies, and Perfusion Technology as well as emerging companies and new technologies from Massachusetts General Hospital , University of Massachusetts Lowell , Harvard Medical School , Northeastern University , University of Massachusetts Amherst , University of Massachusetts Medical School, and Beth Israel Deaconess Medical Center.

Keynote Speaker: Prof. Phillip Zamore Ph.D., UMass Medical School.

Conference Highlights:

Keynote Speaker: Prof. Phillip Zamore Ph.D., UMass Medical School. Phil Zamore, a professor at UMass Medical School and a scientific co-founder of Alnylam will discuss the impact of RNAi both in the lab and in industry. RNAi technology, which Science Magazine called the Breakthrough of the Year in 2002, is a novel technology that can shut down the ability of a specific gene to express. The technology is being used extensively as a research tool to determine how genes work and has huge commercial applications as the basis of new therapeutics. Dr. Zamore was an author and a major contributor to a seminal work between MIT, UMass Medical School and the Max Plank Institute. He continues to be research leader in this field.

Formal company presentations: There will be formal presentations by a select group of early-stage spin-off companies and faculty seeking their first round of professional investment.

Reception and poster session: A networking reception will include poster presentations by all of the presenting companies and by additional institutions and incubating companies.

Agenda:

12:45 – 1:15   Registration and Dessert Bar

1:15 – 2:15     Welcome: Abi Barrow, Director of Massachusetts Technology Transfer Center,  Conference Host
Keynote: Prof. Phillip Zamore, UMass Medical School and co-founder of Alnylam.

2:15 – 2:30     Mass Tech Portal Launch

2:30 – 3:15    Company presentations – Session One
Meiogen Biotechnology Corporation
Harvard Medical School , Jose Halperin
P.A. Technologies, LLC
Encapsion

3:15 – 3:30    Coffee Break

3:30 – 5:00   Company presentations – Session Two
SomRx, Inc
IGAN Therapeutics, Inc.
BioBehavioral Diagnostics
Perfusion Technology LLC
University of Massachusetts Medical School
Contego Pharmaceuticals
Northeastern University
Enhanced Medical Systems

5:00 – 7:00    Networking Reception and Poster Session

Sponsorship Information:

$3,000 Sponsorships Available

Sponsorship benefits:

  • Two complementary conference registrations
  • Recognition in pre-event advertising
  • Designation as sponsor in event signage
  • Opportunity to display sponsor literature on literature table
  • Name and/or logo on printed conference materials and Web site
  • One-page service description and contact information in conference book
  • Acknowledgment and thanks at beginning of meeting
  • Early notification of sponsorship opportunities for future events

Speaker Bio

Prof. Phillip Zamore

Ph.D.
UMass Medical School

Phil Zamore, a professor at UMass Medical School and a scientific co-founder of Alnylam will discuss the impact of RNAi both in the lab and in industry. RNAi technology, which Science Magazine called the Breakthrough of the Year in 2002, is a novel technology that can shut down the ability of a specific gene to express. The technology is being used extensively as a research tool to determine how genes work and has huge commercial applications as the basis of new therapeutics. Dr. Zamore was an author and a major contributor to a seminal work between MIT, UMass Medical School and the Max Plank Institute. He continues to be research leader in this field.

Photos

Top